2017, Volume 19, Issue 2
Strategic Study of CAE >> 2017, Volume 19, Issue 2 doi: 10.15302/J-SSCAE-2017.02.020
Strategy and Measurement for Prevention and Control of Hypertension in Canada
1. Key Laboratory of Etiology and Epidemiology of National Health and Family Planning Commission, Harbin Medical University, Harbin 150081, China;
2. Department of Epidemiology, Public Health College, Harbin Medical University, Harbin 150081, China;
3. Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China;
4. The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
Next Previous
Abstract
Hypertension is a public health issue around the world. At present, Canada is one of the few countries that have achieved remarkable success in the prevention and control of hypertension. Canada has accumulated a considerable amount of advanced experience in the control of hypertension and in the implementation of effective measures against it. This article introduces the prevalence of hypertension in Canada and the development of control strategies and measures against hypertension in Canada, including the Canadian Hypertension Society, the Canadian Hypertensive Education Program, public policies, community interventions, and healthcare systems. We summarize these advanced experiences in order to provide a policy-making basis for the development of hypertension prevention and control in China.
Keywords
hypertension ; awareness rate ; control rate ; treatment rate
References
[ 1 ] McAlister FA, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ, 2011, 183(9):1007–1013. link1
[ 2 ] Robitaille C,Dai S,Waters C, et al. Diagnosed hypertension in Can-ada: incidence, prevalence and associated mortality. CMAJ,2012, 184(1):49–56. link1
[ 3 ] Schiffrin EL, Campbell NR, Feldman RD, et al. Hypertension in Canada: Past, Present, and Future. Annals of Global Health, 2016,82(2):288–299. link1
[ 4 ] Chockalingam A,Campbell N,Ruddy T,et al. Canadiannationalhigh blood pressureprevention and controlstrategy.Can J Cardiol,2000, 16(9):1087–1093. link1
[ 5 ] Chockalingam A, Abbott D, Bass M, et al. Recommendations of the Canadian consensus conference on nonpharmacological approaches to the management of high blood pressure. Can Med Assoc J, 1990, 142(12): 1397–1409. link1
[ 6 ] Campbell NRC, Brant R, Johansen H, et al. Increases in antihy-pertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension, 2009, 53(2): 128–134. link1
[ 7 ] McAlister FA, Feldman RD, Wyard K, et al. The impact of the Ca-nadian Hypertension Education Programme in its first decade. Eur Heart J, 2009, 30(12):1434–1439. link1
[ 8 ] Campbell NR, Petrella R, Kaczorowski J. Public education on hypertension: a new initative to improve the prevention, treat-ment and control of hypertension in Canada. Can J Cardiol, 2006, 22(7):599–603. link1
[ 9 ] Sodium Working Group. Sodium reduction strategy for Canada: Recommendations of the sodium working group[R].
[10] Kaczorowski J,Chambers LW,Dolovich L, et al. Improving car-diovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ, 2011(342):d442. link1
[11] Gutkin C. The future of family practice in Canada: the patient’s medical home. Canadian Family Physician, 2011, 57(10):1224. link1
京公网安备 11010502051620号
